Natural Product: NPC474114

Natural Product IDNPC474114
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2Z,6E,10E,14E)-16-(2,5-Dihydroxy-3-Methylphenyl)-1,12-Dihydroxy-2,6,10,14-Tetramethylhexadeca-2,6,10,14-Tetraen-4-One
IUPAC Name (2Z,6E,10E,14E)-16-(2,5-dihydroxy-3-methylphenyl)-1,12-dihydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,14-tetraen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL462112
PubChem CID 44559658
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey GPMAKHULTRCGTA-PNDALFHPSA-N
Standard InCHI InChI=1S/C27H38O5/c1-18(7-6-8-19(2)12-25(30)14-21(4)17-28)11-24(29)13-20(3)9-10-23-16-26(31)15-22(5)27(23)32/h8-9,11,14-16,24,28-29,31-32H,6-7,10,12-13,17H2,1-5H3/b18-11+,19-8+,20-9+,21-14-
SMILES OC/C(=CC(=O)C/C(=C/CC/C(=C/C(C/C(=C/Cc1cc(O)cc(c1O)C)/C)O)/C)/C)/C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   442.27 Volume:   489.851
?
Van der Waals volume.
Dense:   0.903 LogP:   4.299
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.416
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.264
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   12.0 Rigid Bonds:   11.0
TPSA:   97.99
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   4.0 Rings:   1.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.202 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.995 Fsp3:   0.444
MCE-18:   26.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.873 Fluc inhibitor:   0.157
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.201
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.504 Promiscuous compounds:   0.006

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.381 MDCK Permeability:   -4.983
Pgp-inhibitor:   0.113 Pgp-substrate:   0.0
PAMPA:   0.105
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.117 30% Bioavailability (F30%):   0.351
50% Bioavailability (F50%):   0.96

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.908
Plasma Protein Binding (PPB):   82.942% Volume Distribution (VD):   0.13
Fu: 20.235%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.518

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.751 CYP2C19-substrate:   0.024
CYP2C9-inhibitor:   0.004 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.102 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.108 CYP3A4-substrate:   0.307
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.769
HLM stability:   0.447
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.054 Half-life (T1/2):  1.235

ADMET: Toxicity

hERG Blockers:  0.044 hERG Blockers (10um):  0.439
Human Hepatotoxicity (H-HT):  0.775 Drug-induced Liver Injury (DILI):  0.028
AMES Toxicity:  0.073 Rat Oral Acute Toxicity:  0.225
Maximum Recommended Daily Dose:  0.755 Skin Sensitization:  0.969
Carcinogencity:  0.16 Eye Corrosion:  0.0
Eye Irritation:  0.544 Respiratory Toxicity:  0.973
Drug-induced Neurotoxicity:  0.103 Ototoxicity:  0.832
Hematotoxicity:  0.263 Drug-induced Nephrotoxicity:  0.229
Genotoxicity:  0.249 RPMI-8226 Immunitoxicity:  0.052
A549 Cytotoxicity:  0.189 Hek293 Cytotoxicity:  0.68
BCF:   2.06
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.966
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.443
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.71
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8863 Cystoseira crinita Species Sargassaceae Eukaryota n.a. n.a. n.a. PMID[12880316]
NPO8863 Cystoseira crinita Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8863 Cystoseira crinita Species Sargassaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell line HepG2 Homo sapiens GI50 = 1.8 ug.mL-1 PMID[24992075]
NPT65 Cell line HepG2 Homo sapiens TGI = 3.5 ug.mL-1 PMID[23062825]
NPT83 Cell line MCF7 Homo sapiens TGI = 2.5 ug.mL-1 DrugMatrix in vitro pharmacology data
NPT83 Cell line MCF7 Homo sapiens GI50 = 1.6 ug.mL-1 DrugMatrix in vitro pharmacology data
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 9.0 % PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 22.3 % PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 35.3 % PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 67.5 % PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 71.1 % PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 0.9 ug.mL-1 PMID[12880316]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 2.4 ug.mL-1 PMID[12880316]
NPT1 Others Radical scavenging activity n.a. Activity = 7.4 % PMID[8450319]
NPT1 Others Radical scavenging activity n.a. Activity = 16.2 % PMID[25871261]
NPT1 Others Radical scavenging activity n.a. Activity = 30.7 % PMID[22483590]
NPT1 Others Radical scavenging activity n.a. Activity = 79.2 % PMID[16872140]
NPT1 Others Radical scavenging activity n.a. Activity = 95.6 % DOI[10.6019/CHEMBL1201861]
NPT1 Others Radical scavenging activity n.a. Activity = 95.7 % PMID[17488817]
NPT35 Others n.a. n.a. Activity = 0.09 mmol/L PMID[20429578]
NPT2 Others Unspecified n.a. Activity = 0.72 mmol/L PMID[25647077]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC474114 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7812 Intermediate Similarity NPC474050
0.7344 Intermediate Similarity NPC28784
0.7344 Intermediate Similarity NPC296144
0.6984 Remote Similarity NPC208229
0.6719 Remote Similarity NPC282855
0.6719 Remote Similarity NPC26013
0.6667 Remote Similarity NPC68260
0.6667 Remote Similarity NPC279887
0.5385 Remote Similarity NPC278832
0.5385 Remote Similarity NPC64157

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474114 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data